BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
PUT
Conagra Brands
CAG
$7.23B
| $7.82M | ﹤0.01% |
+228,500
| New | +$6.62M |
|
3352
EyePoint Inc
EYPT
$1.2B
| $7.81M | ﹤0.01% |
503,958
+30,309
| +6% | +$540K |
|
|
APLT
3353
DELISTED
Applied Therapeutics
APLT
| $7.79M | ﹤0.01% |
285,605
+264,043
| +1,225% | +$4.52M |
|
|
UBFO
3354
DELISTED
United Security Bancshares
UBFO
| $7.78M | ﹤0.01% |
724,689
+13,610
| +2% | +$141K |
|
|
SHSP
3355
DELISTED
SharpSpring, Inc.
SHSP
| $7.76M | ﹤0.01% |
676,178
+89,814
| +15% | +$915K |
|
3356
Biglari Holdings Class B
BH
$1.21B
| $7.74M | ﹤0.01% |
67,609
-2,657
| -4% | -$271K |
|
3357
United Microelectronic
UMC
$46.9B
| $7.72M | ﹤0.01% |
2,881,114
+590,640
| +26% | +$1.43M |
|
3358
Anavex Life Sciences
AVXL
$310M
| $7.71M | ﹤0.01% |
2,977,213
+91,218
| +3% | +$239K |
|
3359
OP Bancorp
OPBK
$233M
| $7.71M | ﹤0.01% |
743,112
+8,372
| +1% | +$82.3K |
|
|
BITA
3360
DELISTED
Bitauto Holdings Limited
BITA
| $7.7M | ﹤0.01% |
518,823
-18,265
| -3% | -$276K |
|
3361
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
| $7.69M | ﹤0.01% |
150,635
+3,796
| +3% | +$194K |
|
3362
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$4.06B
| $7.66M | ﹤0.01% |
300,045
+45
| +0% | +$1.15K |
|
|
BHR.PRB
3363
Braemar Hotels & Resorts 5.50% Series B Preferred Stock
BHR.PRB
$51.8M
| $7.65M | ﹤0.01% |
402,655
+39,567
| +11% | +$779K |
|
|
ELVT
3364
DELISTED
Elevate Credit, Inc.
ELVT
| $7.62M | ﹤0.01% |
1,711,693
+113,328
| +7% | +$473K |
|
3365
iShares MSCI Thailand ETF
THD
$357M
| $7.6M | ﹤0.01% |
86,724
-1,504
| -2% | -$132K |
|
|
GEN
3366
DELISTED
Genesis Healthcare, Inc.
GEN
| $7.57M | ﹤0.01% |
4,613,704
+19,133
| +0.4% | +$28.7K |
|
3367
Flotek Industries
FTK
$1.28B
| $7.56M | ﹤0.01% |
630,305
+836
| +0.1% | +$9.65K |
|
|
RVLP
3368
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $7.54M | ﹤0.01% |
1,079,526
+605,048
| +128% | +$3.23M |
|
3369
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.37B
| $7.47M | ﹤0.01% |
149,209
+48,459
| +48% | +$2.43M |
|
3370
Neurogene
NGNE
$712M
| $7.47M | ﹤0.01% |
30,323
+14,831
| +96% | +$1.48M |
|
3371
Gildan
GIL
$10.6B
| $7.43M | ﹤0.01% |
+251,728
| New | +$7.37M |
|
3372
Schwab US Broad Market ETF
SCHB
$44.9B
| $7.42M | ﹤0.01% |
579,480
-47,268
| -8% | -$580K |
|
3373
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $7.42M | ﹤0.01% |
97,194
+25,006
| +35% | +$1.83M |
|
3374
Vitamin Cottage Natural Grocers
NGVC
$654M
| $7.41M | ﹤0.01% |
751,314
+9,822
| +1% | +$90.2K |
|
3375
Amplify Energy
AMPY
$166M
| $7.41M | ﹤0.01% |
1,121,288
+69,317
| +7% | +$446K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.